SAB Biotherapeutics (SABS) Enters $20M Equity Sales Agreement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NKE
2. USO
3. SPY
4. ACN
5. NVDA
6. FICO
7. TRU
8. TLT
9. LAES
10. WBD

Go back to SAB Biotherapeutics (SABS) Enters $20M Equity Sales Agreement
(NASDAQ: SABS) Delayed: 2.98 -0.08 (2.61%)
Previous Close $3.06    52 Week High $ 
Open $3.10    52 Week Low $ 
Day High $3.12    P/E N/A 
Day Low $2.96    EPS $ 
Volume 416,319